Table 1

SANADII site characteristics at 7 March 2014

Total sites with MREC approval:128 (%)
Status:
 Participating96 (75)
 No longer participating32 (25)
Participating status:
  (1) Had MREC approval but not yet submitted SSI31 (32)
  (2) Submitted SSI but not yet had R&D approval8 (8)
  (3) R&D approved but Green Light Checklist not yet completed4 (4)
  (4) Green Light Checklist completed but not yet open to recruitment0 (0)
  (5) Site open but not yet recruited first patient15 (16)
  (6) Site open and first patient recruited38 (40)
Recruitment type (of those participating)
 Adult47 (49)
 Paediatrics43 (45)
 Both paediatrics and adult6 (6)
Hospital type (of those participating)
 District general hospital56 (58)
 Health centre2 (2)
 Specialist paediatrics6 (6)
 Specialist tertiary1 (1)
 Teaching hospital31 (32)
Country (of those participating)
 England76 (79)
 Isle of man1 (1)
 Northern Ireland2 (2)
 Scotland7 (7)
 Wales10 (10)
Set up actively supported by Research Network (of those participating):
 NIHR Comprehensive Local Research Network (CLRN)*4 (4)
 NIHR Dementias and Neurodegeneration Network (DenDRoN)*14 (14)
 NIHR Medicines for Children Research Network (MCRN)*24 (25)
 Welsh Epilepsy Research (WERN)6 (6)
 No Network48 (50)
  • *Networks within NIHR Clinical Research Network before it was restructured in April 2014.

  • MREC, Multicentre Regional Ethics Committee; SSI, Site Specific Information; R&D, Research and Development.